237 related articles for article (PubMed ID: 24057239)
1. Association of the costimulatory molecule gene polymorphisms and active cytomegalovirus infection in hematopoietic stem cell transplant patients.
Saadi MI; Yaghobi R; Karimi MH; Geramizadeh B; Ramzi M; Zakerinia M
Mol Biol Rep; 2013 Oct; 40(10):5833-42. PubMed ID: 24057239
[TBL] [Abstract][Full Text] [Related]
2. Relation between costimulatory molecule polymorphism and hepatitis B infections in hematopoietic stem cell transplant recipients.
Yaghobi R; Saadi MI; Karimi MH; Geramizadeh B; Ramzi M; Zakerinia M
Exp Clin Transplant; 2014 Aug; 12(4):357-66. PubMed ID: 24188429
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of costimulatory molecules (CTLA4, ICOS, PD.1 and CD28) and allogeneic hematopoietic stem cell transplantation in Iranian patients.
Iravani-Saadi M; Karimi MH; Yaghobi R; Geramizadeh B; Ramzi M; Niknam A; Pourfathollah A
Immunol Invest; 2014; 43(4):391-404. PubMed ID: 24564845
[TBL] [Abstract][Full Text] [Related]
4. Genetic Variation of Costimulatory Molecules, Including Cytotoxic T-Lymphocyte Antigen 4, Inducible T-Cell Costimulator, Cluster Differentiation 28, and Programmed Cell Death 1 Genes, in Iranian Patients With Leukemia.
Ramzi M; Arandi N; Saadi MI; Yaghobi R; Geramizadeh B
Exp Clin Transplant; 2020 Nov; 18(6):719-724. PubMed ID: 29697355
[TBL] [Abstract][Full Text] [Related]
5. The Association Between Single-Nucleotide Polymorphisms of Co-Stimulatory Genes Within Non-HLA Region and the Prognosis of Leukemia Patients With Hematopoietic Stem Cell Transplantation.
Chen DP; Chang SW; Wang PN; Lin WT; Hsu FP; Wang WT; Tseng CP
Front Immunol; 2021; 12():730507. PubMed ID: 34671352
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of the Costimulatory Genes CTLA-4, CD28, PD-1, and ICOS and Outcome of Kidney Transplants in Iranian Patients.
Niknam A; Karimi MH; Geramizadeh B; Roozbeh J; Yaghobi R; Salehipour M
Exp Clin Transplant; 2017 Jun; 15(3):295-305. PubMed ID: 28031007
[TBL] [Abstract][Full Text] [Related]
7. Association of genetic variation in co-stimulatory molecule genes with outcome of liver transplant in Iranian patients.
Karimi MH; Motazedian M; Abedi F; Yaghobi R; Geramizadeh B; Nikeghbalian S
Gene; 2012 Aug; 504(1):127-32. PubMed ID: 22579879
[TBL] [Abstract][Full Text] [Related]
8. Genetic variations in T-cell activation and effector pathways modulate alloimmune responses after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies.
Xiao H; Luo Y; Lai X; Fu S; Shi J; Tan Y; He J; Xie W; Zheng W; Wang LM; Zhang L; Liu L; Ye X; Yu X; Cai Z; Lin M; Huang H
Haematologica; 2012 Dec; 97(12):1804-12. PubMed ID: 22733023
[TBL] [Abstract][Full Text] [Related]
9. The Association Between Viral Infections and Co-stimulatory Gene Polymorphisms in Kidney Transplant Outcomes.
Niknam A; Karimi MH; Yaghobi R; Geramizadeh B; Roozbeh J; Salehipour M; Iravani M
Jundishapur J Microbiol; 2016 Aug; 9(8):e31338. PubMed ID: 27800130
[TBL] [Abstract][Full Text] [Related]
10. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
Pawlak-Adamska E; Frydecka I; Bolanowski M; Tomkiewicz A; Jonkisz A; Karabon L; Partyka A; Nowak O; Szalinski M; Daroszewski J
Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540
[TBL] [Abstract][Full Text] [Related]
11. Donor Genotype in the Interleukin-7 Receptor α-Chain Predicts Risk of Graft-versus-Host Disease and Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.
Kielsen K; Enevold C; Heilmann C; Sengeløv H; Pedersen AE; Ryder LP; Müller K
Front Immunol; 2018; 9():109. PubMed ID: 29456530
[TBL] [Abstract][Full Text] [Related]
12. Characterization of CD28, CTLA4, and ICOS polymorphisms in three Brazilian ethnic groups.
Guzman VB; Morgun A; Shulzhenko N; Mine KL; Gonçalves-Primo A; Musatti CC; Gerbase-Delima M
Hum Immunol; 2005 Jul; 66(7):773-6. PubMed ID: 16112024
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?
Bouwhuis MG; Gast A; Figl A; Eggermont AM; Hemminki K; Schadendorf D; Kumar R
Cancer Immunol Immunother; 2010 Feb; 59(2):303-12. PubMed ID: 19672595
[TBL] [Abstract][Full Text] [Related]
14. Correlations of programmed death 1 expression and serum IL-6 level with exhaustion of cytomegalovirus-specific T cells after allogeneic hematopoietic stem cell transplantation.
Kato T; Nishida T; Ito Y; Murase M; Murata M; Naoe T
Cell Immunol; 2014; 288(1-2):53-9. PubMed ID: 24657340
[TBL] [Abstract][Full Text] [Related]
15. A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation.
Karabon L; Markiewicz M; Partyka A; Pawlak-Adamska E; Tomkiewicz A; Dzierzak-Mietla M; Kyrcz-Krzemien S; Frydecka I
Immunogenetics; 2015 Jun; 67(5-6):295-304. PubMed ID: 25940108
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation.
Dieamant DC; Bonon SH; Peres RM; Costa CR; Albuquerque DM; Miranda EC; Aranha FJ; Oliveira-Duarte G; Fernandes VC; De Souza CA; Costa SC; Vigorito AC
BMC Infect Dis; 2013 Jul; 13():310. PubMed ID: 23841715
[TBL] [Abstract][Full Text] [Related]
17. Effect of donor STAT4 polymorphism rs7574865 on clinical outcomes of pediatric acute leukemia patients after hematopoietic stem cell transplant.
Wun CM; Piao Z; Hong KT; Choi JY; Hong CR; Park JD; Park KD; Shin HY; Kang HJ
Int Immunopharmacol; 2017 Feb; 43():62-69. PubMed ID: 27960128
[TBL] [Abstract][Full Text] [Related]
18. MICB Genetic Variants and Its Protein Soluble Level Are Associated with the Risk of Chronic GvHD and CMV Infection after Allogeneic HSCT.
Siemaszko J; Dratwa M; Szeremet A; Majcherek M; Czyż A; Sobczyk-Kruszelnicka M; Fidyk W; Solarska I; Nasiłowska-Adamska B; Skowrońska P; Bieniaszewska M; Tomaszewska A; Basak GW; Giebel S; Wróbel T; Bogunia-Kubik K
Arch Immunol Ther Exp (Warsz); 2024 Jan; 72(1):. PubMed ID: 38847554
[TBL] [Abstract][Full Text] [Related]
19. Genetic diversity of CD14, CD28, CTLA-4 and ICOS gene promoter polymorphism in African and American sickle cell disease.
Seamans BN; Pellechio SL; Capria AL; Agyingi SE; Morenikeji OB; Ojurongbe O; Thomas BN
Hum Immunol; 2019 Nov; 80(11):930-936. PubMed ID: 31474499
[TBL] [Abstract][Full Text] [Related]
20. CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer.
Karabon L; Pawlak E; Tomkiewicz A; Jedynak A; Passowicz-Muszynska E; Zajda K; Jonkisz A; Jankowska R; Krzakowski M; Frydecka I
Hum Immunol; 2011 Oct; 72(10):947-54. PubMed ID: 21669243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
